Every study, searchable

Search the studies

  1. Metabolic & GLP-1well supported · human dataAdded 17 August 2026
    Fasted workouts show no metabolic edge over fed ones

    Across 28 trials in 302 healthy adults, single fasted workouts were associated with larger rises in glucose and insulin and larger drops in free fatty acids than fed workouts, with no difference in triglycerides or the body's fuel-use ratio. The pooled results give no support to the idea that fasted sessions are better for glucose or fat metabolism.

    What it shows: Worth taking seriously but deliberately narrow: results pooled from 28 trials in 302 healthy adults, all measuring single workouts lasting 36 to 150 minutes. It says nothing about whether weeks of habitual fasted training change fat loss, fitness or long-term metabolic health.Meta-analysis · Clin Nutr ESPEN

  2. Metabolic & GLP-1well supported · human dataAdded 17 August 2026
    Steady cardio for the scales, HIIT for the waist

    In a pooled comparison of 28 randomised trials in 1,620 adults with overweight or obesity, aerobic exercise ranked best for reducing body weight and BMI, while HIIT ranked best for waist circumference, body fat, triglycerides, fasting glucose and VO2 max. No training mode significantly improved total cholesterol or blood pressure.

    What it shows: A useful ranking rather than a final verdict: results pooled from 28 trials in 1,620 adults with overweight or obesity, comparing four training styles side by side. Rankings like this lean partly on indirect comparisons between trials that never faced each other, so the gaps between modes are less certain than they look.Meta-analysis · Front Endocrinol (Lausanne)

  3. Nutritionwell supported · human dataAdded 17 August 2026
    Fasting 14 hours may match 16 for weight loss

    Fasting for 14 hours a day may be as effective as 16 hours for weight loss, according to a sweep of 24 randomised trials of time-restricted feeding. The pattern produced moderate weight loss in people with overweight or obesity, and losses exceeded 5% of starting body weight when combined with calorie restriction.

    What it shows: Encouraging but not settled: a sweep of 24 trials found consistent short-term benefits in people carrying extra weight, but the trials were mostly brief and the authors themselves call for longer, better designed studies.Systematic review · Nutrients

  4. Nutritionwell supported · human dataAdded 17 August 2026
    Fasting is not magic: the calorie cut does the work

    Across 167 trials with 11,998 adults, intermittent fasting patterns produced weight loss comparable to ordinary calorie restriction of the same size, and fasting regimens showed weight rebound after 12 weeks while continuous restriction did not. What mattered was the depth of the energy cut, not the meal timing.

    What it shows: Strong evidence: results pooled from 167 trials in 11,998 adults with overweight, obesity or metabolic problems. Certainty ranged from low to high across the comparisons, and the rebound finding comes from a subgroup analysis, so it is the least firm piece.Meta-analysis · Nutr Rev

  5. Nutritionwell supported · human dataAdded 17 August 2026
    Early eating windows burn fat and spare muscle

    Eating earlier in the day under early time-restricted eating cut body weight by 1.84 kg, fat mass by 1.10 kg and visceral fat area by 9.76 cm2 versus unrestricted eating across 13 pooled trials, without a significant loss of fat-free mass. A 16:08 schedule, sixteen hours fasting to eight hours eating, looked best at preserving lean tissue.

    What it shows: Fairly convincing on fat loss: results pooled from 13 trials in 859 people pointed the same way. The muscle-sparing conclusion is shakier, since the change in lean mass only just missed statistical significance and the trials were short.Meta-analysis · Diabetes Metab Syndr

  6. Bones & Jointswell supported · human dataAdded 17 August 2026
    Yoga eases back pain, but no better than standard physio exercise

    Across 18 randomised trials, yoga reduced chronic low back pain versus no exercise for up to 6 to 7 months and improved disability for up to 12 months, but it was no better than physical therapy exercise on either outcome, and quality of life did not improve.

    What it shows: Believable but unglamorous: results pooled from 18 trials, with the strength of the evidence ranging from very low to moderate. The pain benefit had faded by the 12-month mark, and yoga showed no edge over ordinary exercise at any point.Meta-analysis · PLoS One

  7. Bones & Jointspreliminary · human dataAdded 17 August 2026
    Softer landings, not new shoes, may protect runners' knees

    Runners retrained to land more softly had roughly two-thirds lower risk of knee injury in one trial of 320 people. Meanwhile footwear choices, graduated running programmes, multicomponent exercise and injury-prevention education showed no influence on knee injury risk across 17 other prevention trials.

    What it shows: Promising but fragile: the standout result comes from a single trial of 320 runners, rated low certainty within a wider sweep of 30 trials in new and recreational runners. It needs repeating before it counts as anything like settled.Meta-analysis · Br J Sports Med

  8. Supplementswell supported · human dataAdded 16 August 2026
    Zinc could knock 2.25 days off a common cold

    In pooled results from randomised trials, zinc supplementation taken on its own was linked to colds ending about 2.25 days sooner in healthy adults. Other micronutrients, including vitamin D and vitamins A and E, did not appear to prevent colds or ease symptom severity.

    What it shows: Worth taking seriously: this sweep of all the trial evidence pooled 10 zinc trials in healthy adults, and the 2.25-day saving appeared only when zinc was taken by itself. The plausible range around that figure is wide, so the exact size of the benefit is not pinned down.Systematic review · Am J Trop Med Hyg

  9. Metabolic & GLP-1well supported · human dataAdded 16 August 2026
    Tirzepatide lowers blood pressure so much it can go too low

    Pooled results from 32 randomised trials covering 47,332 people with type 2 diabetes or obesity linked tirzepatide to a 60% lower risk of hypertension-related adverse events but roughly two and a half times the risk of hypotension-related events, especially at higher doses. Semaglutide showed no significant link with blood pressure events in either direction.

    What it shows: Strong pooled evidence: 32 trials where people were assigned at random, covering 47,332 people with type 2 diabetes or obesity. The catch is that these were side effects logged during drug trials built for other questions, not studies designed to measure blood pressure itself.Meta-analysis · Endocrine

  10. Hormoneswell supported · human dataAdded 16 August 2026
    Underactive thyroid predicts dying from heart disease, not getting it

    Across nine studies of 9,662 adults, people with hypothyroidism had 2.73 times the odds of cardiovascular death compared with those with normal thyroid function, yet showed no increased odds of developing cardiovascular events in the first place.

    What it shows: Take the mortality link seriously but not as proof of cause: results pooled from nine studies that followed 9,662 adults rather than testing any treatment. The absence of a link with developing heart disease was not significant, which the authors stress is not the same as showing no effect.Meta-analysis · Endocrine

  11. Supplementswell supported · human dataAdded 16 August 2026
    Creatine adds strength for older women, especially past 24 weeks

    Pooled data from ten randomised trials in 211 older women show that adding creatine to resistance training improves upper-body strength, with both upper- and lower-body strength improving when programmes lasted at least 24 weeks. Measures of muscle mass did not change.

    What it shows: Promising but thin: results pooled from ten trials covering just 211 older women, and the authors themselves call for higher-quality studies to confirm it. Strength improved, yet muscle size showed no measurable change.Meta-analysis · Nutrients

  12. Supplementswell supported · human dataAdded 16 August 2026
    Nitrate's performance boost vanishes in the fittest athletes

    Across 80 randomised crossover studies in young healthy adults, dietary nitrate supplementation produced a small but clear improvement in exercise performance. The benefit appeared in recreationally active young men but was not observed in women-only studies or in well-trained endurance athletes.

    What it shows: About as solid as supplement evidence gets for the headline effect, pooling 80 trials, but the boost is small and the studies were mostly of young healthy men. Only six tested women alone, so the blank result in women may simply reflect missing data.Meta-analysis · Med Sci Sports Exerc

  13. Trainingwell supported · human dataAdded 16 August 2026
    Exercise order barely matters for muscle, but it decides where you get strong

    A meta-analysis of eleven trials found muscle growth was similar whether sessions started with big compound lifts or isolation exercises, but strength gains were largest in whichever exercises were performed first in the session.

    What it shows: Solid as far as it goes: results pooled from eleven good to excellent quality trials all point the same way. It cannot say whether the pattern holds over years of training or in every type of lifter, and muscle growth was measured in different ways across the trials.Meta-analysis · Eur J Sport Sci

  14. Cardiowell supported · human dataAdded 16 August 2026
    HIIT holds its own after 60, and may edge out steady cardio

    Pooled results from 29 trials in 1,227 adults aged 60 and over show HIIT and moderate continuous cardio produced similar gains in fitness, blood pressure, blood sugar and body fat percentage, but only HIIT significantly reduced fat mass and waist circumference and improved a cognitive test.

    What it shows: Strong overall: results pooled from 29 trials in 1,227 people aged 60 and over. HIIT's extra edge appeared mainly in the better controlled trials, so exactly how big that advantage is remains open.Meta-analysis · Arch Gerontol Geriatr

  15. Supplementswell supported · human dataAdded 16 August 2026
    Beetroot juice can lift endurance, but caffeine may cancel it out

    A systematic review of 23 studies found beetroot juice can improve cardiorespiratory endurance in athletes, increasing efficiency and time to exhaustion at submaximal intensities, though combining it with other supplements such as caffeine may undermine the effect.

    What it shows: Fairly persuasive but not settled: a sweep of 23 studies in athletes mostly pointed the same way, though the authors note some findings contradict each other. No numbers were pooled, so the size of the benefit is unclear.Systematic review · Nutrients

  16. Mindwell supported · human dataAdded 16 August 2026
    Aromatherapy really does take the edge off anxiety

    Aromatherapy delivered by inhalation or massage significantly lowered anxiety scores across 32 randomised trials, regardless of the cause of the anxiety, with state anxiety falling by about 5 points on average.

    What it shows: Worth some weight, but the benefit is modest: results pooled from 32 trials showed roughly a 5 point drop on a standard anxiety questionnaire. The trials covered patients with all sorts of anxiety, and none of them settled which oil or what dose works best.Meta-analysis · J Affect Disord

  17. Supplementswell supported · human dataAdded 16 August 2026
    Soy protein keeps pace with whey for muscle

    Across 19 randomised trials of active people aged 14 to 39, soy protein produced lean mass gains identical to whey in some studies and showed potential endurance performance benefits at doses of 10 to 53.3 g, while its effects on testosterone and cortisol were inconsistent.

    What it shows: A sweep of all 19 randomised trials on this in active people aged 14 to 39, but the picture is patchy: soy matched whey only in some studies, hormone findings flipped between trials, and results on aerobic capacity conflicted. This is soy holding its own rather than beating whey.Systematic review · Sports Med

  18. Women's Healthwell supported · human dataAdded 16 August 2026
    Menopause mood dips respond to even gentle exercise

    Across 21 randomised trials involving 2020 women in the menopausal transition and after menopause, physical activity reduced both depressive and anxiety symptoms compared with controls, with low and moderate intensity exercise proving similarly effective.

    What it shows: The direction is convincing, the exact size less so: results pooled from 21 trials of 2020 women showed clear mood benefits, but the trials disagreed with each other a lot about how large they are. The anxiety findings also rest on fewer studies than the depression ones.Meta-analysis · Int J Behav Nutr Phys Act

  19. Metabolic & GLP-1well supported · human dataAdded 16 August 2026
    Semaglutide loses the weight loss crown to retatrutide

    In a pooled comparison of 27 randomised trials covering 15,584 people with obesity or overweight, retatrutide 12 mg cut body weight by 22.10% versus placebo, ahead of retatrutide 8 mg at 20.70% and tirzepatide 15 mg at 16.53%, making multi-hormone agonists more effective than single GLP-1 drugs including semaglutide.

    What it shows: About as strong as it gets short of direct head-to-head trials: results pooled from 27 trials of 15,584 people, though most drugs were compared through a shared placebo rather than against each other directly. People with type 2 diabetes lost noticeably less weight on the same drugs.Meta-analysis · Metabolism

  20. Women's Healthpreliminary · human dataAdded 16 August 2026
    GLP-1 drugs trim waists and testosterone in PCOS

    In four randomised trials of 176 women with PCOS and obesity, GLP-1 drugs reduced waist circumference by 5.16 cm, BMI by 2.42 points and total testosterone compared with placebo, but did not significantly change total cholesterol or insulin resistance scores.

    What it shows: Promising but thin: just four trials and 176 women in total, so these numbers could easily move as larger trials report. Insulin resistance and cholesterol showed no clear change, and mild stomach side effects such as nausea were common.Meta-analysis · J Diabetes Complications

  21. Women's Healthwell supported · human dataAdded 16 August 2026
    Weight loss moves the needle on PCOS, but not every symptom

    Across 29 randomised comparisons in 1529 people with PCOS, weight loss interventions improved insulin resistance, free androgen levels and menstrual frequency compared with usual care, but showed no clear improvement in hirsutism or quality of life.

    What it shows: A careful sweep of the trials but a messy evidence base: 29 comparisons in 1529 women mixed diets, GLP-1 drugs and other medicines, and the studies disagreed with each other a lot. Nearly half were at high risk of bias, so the exact sizes of the benefits are soft.Meta-analysis · Ann Intern Med

  22. Gut & Microbiomewell supported · human dataAdded 16 August 2026
    Fibre boosts specific gut bacteria, not overall diversity

    Dietary fibre interventions raised the abundance of Bifidobacterium and Lactobacillus species and faecal butyrate in healthy adults, but did not change overall microbial diversity, in results pooled from 64 randomised trials with 2099 participants. Fructans and galacto-oligosaccharides drove the largest bacterial gains.

    What it shows: Solid ground: results pooled from 64 trials in 2099 healthy adults, so the bacterial shifts look real. But the fibres and lab methods varied between studies, and higher counts of these bacteria are not yet proof of better health.Meta-analysis · Am J Clin Nutr

  23. Cardiowell supported · human dataAdded 16 August 2026
    HIIT edges out steady cardio for aerobic fitness in older adults

    In older adults, high-intensity interval training improved peak oxygen uptake more than moderate-intensity continuous training across pooled randomised trials, alongside favourable changes in muscle power, cardiac function, blood triglycerides and glucose. Subgroups suggested programmes longer than 12 weeks at 2 sessions per week worked best.

    What it shows: Reasonably firm: results pooled from randomised trials in older adults, so the direction is trustworthy. The fitness edge over steady cardio was modest, though, and the training recipes varied widely from study to study, so the ideal formula is a hint rather than a rule.Meta-analysis · Exp Gerontol

  24. Women's Healthwell supported · human dataAdded 16 August 2026
    Gentle aerobic exercise takes hours off period pain

    Aerobic exercise reduced period pain intensity and shortened pain duration by an average of 12.53 hours in results pooled from 16 randomised trials involving 918 adolescents and young women with primary dysmenorrhoea. Pilates, low-intensity formats and a frequency of two or fewer sessions per week showed the largest effects.

    What it shows: Encouraging but messy: results pooled from 16 trials in 918 adolescents and young women, yet the trials disagreed with each other considerably on how big the relief was. The direction is consistent; the exact size of the benefit is not settled.Meta-analysis · Acta Obstet Gynecol Scand

Back to the full archive · this week’s studies